We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
MetLife's (MET) My Leave Navigator to Boost Leave Experience
Read MoreHide Full Article
MetLife, Inc. (MET - Free Report) recently unveiled My Leave Navigator, a new digital tool designed to enhance the employee experience from pre-leave planning to accessing different employer-sponsored programs. This offering, integrated into MetLife's MyBenefits suite, aims to provide personalized, intuitive support for employees taking leave due to various life events, including expansion of their families, caring for family members, or recovering from an illness.
The company's recent research highlights that 62% of employees lack full confidence in their knowledge of all available benefits. Additionally, 38% of employees who feel neglected at work believe that they were not adequately informed about beneficial programs by their employers.
This emphasizes the high demand for services like My Leave Navigator. MetLife introducing tailored products according to the market demand, enables it to diversify its portfolio and generate steady premiums.
My Leave Navigator is customized to meet the unique needs of each employee's leave situation. It assists employees in comprehending their available options while ensuring they feel supported throughout the entire leave process.
Additionally, the digital solution connects employees' disability insurance with other employer-sponsored programs, like the Paid Family Medical Leave and Family Medical Leave Act, to offer cohesive support.
The new product is expected to generate a sense of support in employees, which is expected to lead to increased loyalty and productivity. It is likely to help them focus on significant life events without the added stress of managing multiple claims, thereby delivering an efficient leave experience.
Price Performance
MetLife’s shares have gained 39.2% in the past year, outperforming the 24.5% growth of the industry.
The Zacks Consensus Estimate for Ambac Financial’s current-year earnings is pegged at $1.45 per share, which witnessed one upward estimate revision in the past month against no movement in the opposite direction. AMBC beat earnings estimates in all the past four quarters, with an average surprise of 893.5%.
The Zacks Consensus Estimate for Brown & Brown’s current-year earnings is pegged at $3.61 per share, which indicates 28.5% year-over-year growth. It has witnessed six upward estimate revisions against none in the opposite direction during the past month. BRO beat earnings estimates in each of the past four quarters, with an average surprise of 11.9%.
The consensus mark for ROOT’s current-year earnings indicates a 35.6% year-over-year improvement. It beat earnings estimates in all the past four quarters, with an average surprise of 34.1%. Furthermore, the consensus estimate for Root’s 2024 revenues suggests 125.3% year-over-year growth.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
MetLife's (MET) My Leave Navigator to Boost Leave Experience
MetLife, Inc. (MET - Free Report) recently unveiled My Leave Navigator, a new digital tool designed to enhance the employee experience from pre-leave planning to accessing different employer-sponsored programs. This offering, integrated into MetLife's MyBenefits suite, aims to provide personalized, intuitive support for employees taking leave due to various life events, including expansion of their families, caring for family members, or recovering from an illness.
The company's recent research highlights that 62% of employees lack full confidence in their knowledge of all available benefits. Additionally, 38% of employees who feel neglected at work believe that they were not adequately informed about beneficial programs by their employers.
This emphasizes the high demand for services like My Leave Navigator. MetLife introducing tailored products according to the market demand, enables it to diversify its portfolio and generate steady premiums.
My Leave Navigator is customized to meet the unique needs of each employee's leave situation. It assists employees in comprehending their available options while ensuring they feel supported throughout the entire leave process.
Additionally, the digital solution connects employees' disability insurance with other employer-sponsored programs, like the Paid Family Medical Leave and Family Medical Leave Act, to offer cohesive support.
The new product is expected to generate a sense of support in employees, which is expected to lead to increased loyalty and productivity. It is likely to help them focus on significant life events without the added stress of managing multiple claims, thereby delivering an efficient leave experience.
Price Performance
MetLife’s shares have gained 39.2% in the past year, outperforming the 24.5% growth of the industry.
Image Source: Zacks Investment Research
Zacks Rank & Key Picks
MetLifecurrently has a Zacks Rank #3 (Hold).
Some better-ranked stocks in the broader Finance space are Ambac Financial Group, Inc. (AMBC - Free Report) , Brown & Brown, Inc. (BRO - Free Report) and Root, Inc. (ROOT - Free Report) , each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for Ambac Financial’s current-year earnings is pegged at $1.45 per share, which witnessed one upward estimate revision in the past month against no movement in the opposite direction. AMBC beat earnings estimates in all the past four quarters, with an average surprise of 893.5%.
The Zacks Consensus Estimate for Brown & Brown’s current-year earnings is pegged at $3.61 per share, which indicates 28.5% year-over-year growth. It has witnessed six upward estimate revisions against none in the opposite direction during the past month. BRO beat earnings estimates in each of the past four quarters, with an average surprise of 11.9%.
The consensus mark for ROOT’s current-year earnings indicates a 35.6% year-over-year improvement. It beat earnings estimates in all the past four quarters, with an average surprise of 34.1%. Furthermore, the consensus estimate for Root’s 2024 revenues suggests 125.3% year-over-year growth.